Kulkarni RN. Identifying biomarkers of subclinical diabetes. Diabetes. 2012;61(8):1925–1926.

Kulkarni RN, Mizrachi E-B, Ocana AG, Stewart AF. Human beta cell proliferation and intracellular signaling: driving in the dark without a roadmap. Diabetes. 2012;61(9):2205–2213.

Goldfine A, Kulkarni R. Insulin modulation of beta cell function: a translational journey from the bench to the bedside. Diabetes, Obesity and Metabolism. 2012;14:152–160.

Teo AKK, Kulkarni RN. Setting sail for glucose homeostasis with the AKAP150-PP2B-anchor. The EMBO journal. 2012;31(20):3956–3957.

Negahdar M, Aukrust I, Johansson BB, Molnes J, Molven A, Matschinsky FM, S\ovik O, Kulkarni RN, Flatmark T, Nj\olstad PR, et al. GCK-MODY diabetes associated with protein misfolding, cellular self-association and degradation. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2012;1822(11):1705–1715.

Zhou J-Y, Dann GP, Liew CW, Smith RD, Kulkarni RN, Qian W-J. Unraveling pancreatic islet biology by quantitative proteomics. Expert review of proteomics. 2011;8(4):495–504.

Kawamori D, Kulkarni RN. Molecular mechanism underlying the intra-islet regulation of glucagon secretion. Diabetes: Damages and Treatments. 2011:139.

Kim W, Doyle M aire E, Liu Z, Lao Q, Shin Y-K, Carlson OD, Kim HS, Thomas S, Napora JK, Lee EK, et al. Cannabinoids inhibit insulin receptor signaling in pancreatic $\beta$-cells. Diabetes. 2011;60(4):1198–1209.

Hinault C, Kawamori D, Liew CW, Maier B, Hu J, Keller SR, Mirmira RG, Scrable H, Kulkarni RN. Delta 40 isoform of p53 controls b-cell proliferation and glucose homeostasis in mice. Diabetes. 2011;60(4):1210–1222.

Reiner T, Thurber G, Gaglia J, Vinegoni C, Liew CW, Upadhyay R, Kohler RH, Li L, Kulkarni RN, Benoist C, et al. Accurate measurement of pancreatic islet beta-cell mass using a second-generation fluorescent exendin-4 analog.. Proceedings of the National Academy of Sciences. 2011;108(31):12815–12820.